Literature DB >> 2704012

Severe herpes zoster infection in the United Kingdom: experience in a regional infectious disease unit.

P Bannister1, B Crosse.   

Abstract

Seventy-three cases of severe herpes zoster infection admitted to a regional infectious disease unit over a 3-year period were reviewed. Complications were common. Elderly patients were in the majority (55%), were hospitalized for longer and accounted for 78% of all complications. Acyclovir therapy was used in 44 cases with a reduction in both the duration of hospital stay and complication rate.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2704012      PMCID： PMC1292038          DOI： 10.1177/014107688908200310

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


  11 in total

1.  Herpes zoster in general practice.

Authors:  C A Ross; W K Brown; A Clarke; W F Caldwell; E R Gordon; J Harvey; A M McAlister; J McGlone; R T Prentice; W Thorburn; C Tobias
Journal:  J R Coll Gen Pract       Date:  1975-01

2.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

3.  Herpes zoster at the NIH: a 20 year experience.

Authors:  M H Mazur; R Dolin
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

4.  Oral acyclovir for herpes zoster.

Authors:  M W McKendrick; J I McGill; A M Bell; E Hickmott; C Burke
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

5.  Oral acyclovir for herpes zoster.

Authors:  R Finn; M A Smith
Journal:  Lancet       Date:  1984-09-08       Impact factor: 79.321

Review 6.  Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

7.  Therapy of acute herpes zoster with acyclovir in the nonimmunocompromised host.

Authors:  V Esmann; J Ipsen; N A Peterslund; K Seyer-Hansen; H Schønheyder; H Juhl
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

8.  Selective decline in cellular immune response to varicella-zoster in the elderly.

Authors:  A E Miller
Journal:  Neurology       Date:  1980-06       Impact factor: 9.910

9.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

10.  Zoster in the elderly: clinical, immunologic and therapeutic considerations.

Authors:  J P Harnisch
Journal:  J Am Geriatr Soc       Date:  1984-11       Impact factor: 5.562
View more
  5 in total

1.  The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster.

Authors:  G P Garnett; B T Grenfell
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

2.  Treatment of shingles and post-herpetic neuralgia.

Authors: 
Journal:  BMJ       Date:  1989-08-05

3.  Treatment of shingles and post-herpetic neuralgia.

Authors: 
Journal:  BMJ       Date:  1989-09-16

4.  Not so simple cystitis: how should prescribers be supported to make informed decisions about the increasing prevalence of infections caused by drug-resistant bacteria?

Authors:  P Davey; D Steinke; T MacDonald; G Phillips; F Sullivan
Journal:  Br J Gen Pract       Date:  2000-02       Impact factor: 5.386

5.  Incidence of acute complications of herpes zoster among immunocompetent adults in England: a matched cohort study using routine health data.

Authors:  H J Forbes; K Bhaskaran; D Grint; V H Hu; S M Langan; H I McDonald; C Morton; L Smeeth; J L Walker; C Warren-Gash
Journal:  Br J Dermatol       Date:  2021-01-04       Impact factor: 9.302
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.